undamentalytics Newsletter

Skinhealth Systems Inc. income statement

In fiscal 2025, Skinhealth Systems Inc. reported revenue of $301m, down 10.0% on the year before, operating income of −$20.8m (a -6.9% margin) and net income of −$9.5m, or −$0.16 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Skinhealth Systems Inc.: income statement, annual
Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue167119260366398334301290
Cost of revenue60528211724315210498
Gross profit10767179249155182196192
Research and development538810666
Selling and marketing62501121601441189489
General and administrative273199106131125118102
Operating income13−17−40−26−131−68−21−4
Interest expense——121314101925
Income before tax−3−38−38145−102−30−6−24
Income tax−1−9−21−2−045
Net income−2−29−37944−100−29−10−28
Diluted EPS−$0.02−$0.28−$3.71−$0.23−$0.76−$0.36−$0.16−$0.21
Diluted shares (average)96m103m102m149m132m142m136m135m
EBITDA15−15−35−19−120−58−17−2

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AXGN vs SKINKIDS vs SKINLMAT vs SKIN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Skinhealth Systems Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Skinhealth Systems Inc.